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The Amplatzer Vascular Plugs (AVP) are self-expandable devices made
from a nitinol wire mesh that have been used to occlude various collateral ves-
sels and shunts in congenital heart disease. We report here our experience.
Methods: From 2004 to 2012, 49 procedures with AVP were realized in
41 patients (17 females and 24 males). AVPs were employed to occlude sys-
temic venous shunts (n=14) mainly in Fontan circulation, arterial systemic
shunts (n=7), arterio-venous fistulas in Rendu-Osler (n=8), patent vertical vein
following total repair of TAPVD (n=5), arterial systemic sequestration in
Scimitar syndrome (n=4), fenestration (n=4) and miscellaneous lesions
(Blalock shunt, n=2; coronary fistulas, n=2; VSD, n=1; aneurysm, n=1; patent
ductus arteriosus, n=1). 
Results: Mean age of patients was 13.8±10.5 years, mean weight
28±11 kg. Thirty one received plug I (mean size 8.3±4.0 mm), 24 pts the plug
IV (mean size 5.5±1.5 mm), and 4 pts the Plug II (mean size 17±4 mm).
Implantation succeeded in all but 3 in whom the plug was retrieved. One
patient with PDA underwent surgical ligation subsequently, a second had suc-
cessful occlusion of a Blalock shunt with another plug, and the remaining had
complete VSD occlusion with another larger device. One device embolized in
pulmonary artery that could be retrieved during the procedure. The fluoro-
scopic time was 19±12 minutes. Full occlusion was confirmed by control
angiography, CT scan or echocardiography. During follow-up, no evidence of
hemodynamic or vascular compromise was noticed.
Conclusion: AVPs are effective and safe in the treatment of collateral vessels
and shunts. The AVP IV is especially useful in embolizing difficult-to-reach, tor-
tuous vessels with small delivery catheter; it is a good alternative to coils. Plugs
I and II are appropriate for occlusion of larger vascular shunts. Choice of AVP is
mainly determined by the anatomy and morphology of the shunt.
